SlideShare a Scribd company logo
LOWER RESPIRATORY TRACT
INFECTIONS
• Infections of the lower respiratory tract includes –
– Acute bronchitis
– Pneumonia
– Pneumothorax
– Atelectasis
– Tuberculosis
– Pertussis
– Lung abscess
– Pulmonary embolism
– Plural effusion
LRTIs
Presented by –
SHUBHRIMA KHAN
RINMS, DURGAPUR
1. According to the causative organisms
(a)Bacterial :-
• Pneumococcal pneumonia caused by Streptococcus pneumoniae*
• Staphylococcal pneumonia caused by Staphylococcus aureus
• Influenzal pneumonia caused by Haemophiles influenza
• Gram-negative bacterial pneumonia caused by Klebsiella
pneumonia
CLASSIFICATION
b) Viral:- Rhinovirus, coronaviruses, influenza virus, respiratory syncytial
virus (RSV), adenovirus and parainfluenza. People following organ
transplantation or immunocompromised present high rates of
cytomegalovirus pneumonia.
c) Fungal:- Fungal pneumonia caused by histoplasmosis, aspergillosis,
candidiasis, blastomycosis
d) Parasitic:- Parasitic pneumonia (caused by protozoa, nematodes,
Platyhelminthes)
CONT..
2. According to the environment
a) Community-acquired pneumonia.
b) Hospital acquired pneumonia.
c) Ventilator acquired Pneumonia. (VAP)
d) Pneumonia in the immuno-compromised host (opportunistic
pneumonia).
e) Aspiration pneumonia
CONT..
3. According to the areas of the lung involved/affected
a) Lobar pneumonia
b) Multilobed pneumonia
c) Bronchial pneumonia
d) Interstitial pneumonia
e) Alveolar (acinar) pneumonia
f) Segmental pneumonia
CONT..
• There are many causes of pneumonia including bacteria, viruses,
mycoplasmas, fungal agents and protozoa.
• It may also result from inhalation of toxic or caustic chemicals, smoke,
dusts or gases or aspiration of food, fluids, or vomitus.
• Pneumonia may complicate to chronic illnesses.
ETIOLOY
• Age 60 or older
• Smoking
• Air pollution, Inhalation of noxious substances.
• Altered consciousness : Alcoholism, head injury, anesthetic drug overdose
• Tracheal intubation
• Upper Respiratory Tract Infection
• Chronic Disease : Chronic lung disease, Diabetes mellitus, heart disease,
cancer
RISK FACTORS
• Immunosuppression
• Malnutrition
• Prolonged bed rest and immobility
• Aspiration of fluid, liquid, foreign or gastric content.
• Prolonged hospital stay.
• Residence in institutional areas where transmission is prone.
CONT..
• Fever
• Chills and sweating
• Productive cough
• Shortness of breath
• Chest pain
• Hypoxemia
• Fatigue
• Dyspnea, Tachypnea
CLINICAL MANIFESTATION
• Hemoptysis
• Headache
• Crackling sounds over affected area
• Dullness on percussion
• Decrease in breath sounds
• Unequal chest expansion
CONT..
• Physical examination.
• Chest X-ray.
• Gram stain and culture and sensitivity tests of sputum.
• Blood culture.
• Immunologic test to detect microbial antigens.
• CT Scan thorax.
• Fiberoptic bronchoscopy or transcutaneous needle aspiration [biopsy].
• ABG.
DIAGNOSTIC EVALUATION
• Appropriate antibiotic therapy
– Macrolide antibiotics: inhibitors of bacterial protein synthesis such as
azithromycin, clarithromycin
– Fluroquinolones: inhibitors of DNA synthesis such as moxifloxacin,
levofloxacin
–  lactams: inhibitors of bacterial cell wall synthesis (Penicillin,
amoxicillin, clavulanate (Augmentin), ceftriaxone, cefuroxime,
tazobactam, meropenem)
• Antipyretic
• Analgesic
• Bronchodilators medications: albuterol sulphate, metaproterenol or
methylxanthines.
MANAGEMENT
• Oxygen therapy
• Nutritional support
• Fluid and electrolyte management
• Deep breathing exercises and spirometry
• Chest physiotherapy
• Nasotracheal suctioning
CONT..
NURSING DIAGNOSIS
1. Impaired gas exchange related to presence of retained secretions at the
capillary alveolar membrane evidenced by cyanosis, dyspnea, confusion,
hypoxia
INTERVENTION
• Assess the respiratory status, skin colour, mental status, heart rhythm and
body temperature.
• Auscultate lung fields.
• Elevate head of bed.
• Suctioning is to be done as indicated.
• Encourage fluids to at least 2500 mL per day, unless contraindicated.
NURSING MANAGEMENT
• Assist with and monitor effects of nebulizer treatments and other.
• Perform chest physiotherapy, incentive spirometer.
• Administer medications, as indicated, for example, mucolytics,
expectorants, bronchodilators, and analgesics.
• Provide supplemental fluids such as IV infusion, humidified oxygen, and
room humidification.
• Monitor serial chest x-rays, ABGs, and pulse oximetry readings.
CONT..
NURSING DIAGNOSIS
2. Ineffective breathing pattern related to inflammation and pain evidenced
by Changes in respiratory rate, diminished/adventitious breath sounds,
Ineffective cough.
INTERVENTION
• Assess rate, depth of respirations and chest movement.
• Elevate head and encourage frequent position changes, deep breathing,
and effective coughing.
• Maintain bedrest
• Monitor ABGs and pulse oximetry.
• Administer oxygen therapy by appropriate
CONT..
NURSING DIAGNOSIS
3. Activity Intolerance relate to imbalance between oxygen supply and demand,
General weakness evidenced by report of weakness, fatigue, exertional
dyspnea or tachypnea, Abnormal heart rate response to activity.
INTERVENTION
• Evaluate client's response to activity.
• Note reports of dyspnea, increased weakness and fatigue, and changes in vital
signs during and after activities
• Provide a quiet environment and limit visitors during acute phase
• Encourage use of stress management and diversional activities.
• Explain importance of balancing activities with rest.
• Assist with self-care activities as necessary.
CONT..
NURSING DIAGNOSIS
4. Knowledge deficit regarding condition, treatment, self care, discharge
needs, related to lack of exposure , information misinterpretation as
evidenced by reports the problem, inaccurate follow-through of
instructions.
INTERVENTION
• Assess the level of understanding of the patient and knowledge.
• Explain about the disease condition, its signs and symptoms and
treatment modalities.
• Explain and demonstrate about the importance of effective coughing and
deep breathing exercises.
CONT..
• Emphasis necessity of continuing antimicrobial therapy.
• Explain about balanced rest and activity, avoiding smoking, well-rounded
diet, and avoidance of crowds during cold and flu season and of persons
with upper respiratory infections.
• Stress importance of continuing medical follow-up and obtaining
vaccinations and immunizations as appropriate for both children and
adults.
CONT..
NURSING DIAGNOSIS
5. Deficient fluid volume R/t fever, diaphoresis & mouth breathing.
6. Imbalanced nutrition: less than body requirements R/t dyspnea, poor
oral intake.
7. Pain R/t frequent coughing
8. Impaired oral mucous membrane R/t mouth breathing & frequent cough.
CONT..
• Advise patient to complete entire course of antibiotics.
• Once clinically stable, encourage gradual increase in activities to bring
energy level back to pre-illness stage.
• Encourage breathing exercises.
• Explain that a chest X-ray is usually taken 4 to 6 weeks after recovery.
• Advise smoking cessation and avoid excessive alcohol intake.
• Advise patient to keep up natural resistance with good nutrition and
adequate rest.
• Advice patient to practice frequent handwashing, especially after contact
with others.
PATIENT EDUCATION
Bronchitis is inflammation or swelling of the bronchial tubes (bronchi).
More specifically, bronchitis is when the lining of the bronchial tubes
becomes inflamed or infected.
DEFINITION
Acute bronchitis
Acute bronchitis is a shorter illness that commonly follows a cold or viral
infection, such as the flu. Acute bronchitis usually lasts a few days or weeks
Chronic bronchitis
Chronic bronchitis is characterized by a persistent, mucus-producing cough
on most days of the month, three months of a year for two successive years
in absence of a secondary cause of the cough.
TYPES
• Viruses, bacteria, and other particles that irritate the bronchial tubes.
• Smokers: People who are exposed to a lot of secondhand smoke
• People with weakened immune systems
• The elderly and infants
• People with gastroesophageal reflux disease (GERD)
• People who are exposed to air pollution
ETIOLOGY
• Coughing
• Production of clear, white, yellow, grey, or green mucus (sputum)
• Shortness of breath
• Wheezing
• Fatigue
• Fever and chills
• Chest pain or discomfort
• Blocked or runny nose
CLINICAL MANIFESTATIONS
History collection
Physical examination
Chest x- rays
Sputum cultures
Pulmonary function test
Bronchoscopy
INVESTIGATIONS
• Antibiotics - these are effective for bacterial infections, but not for viral
infections. They may also prevent secondary infections.
• Cough medicine - one must be careful not to completely suppress the
cough, for it is an important way to bring up mucus and remove irritants
from the lungs.
• Bronchodilators - these open the bronchial tubes and clear out mucus
MEDICAL MANAGEMENT
• Mucolytics - these thin or loosen mucus in the airways, making it easier
to cough up sputum.
• Anti-inflammatory medicines and glucocorticoid steroids - these are
for more persistent symptoms.
• Pulmonary rehabilitation program - this includes work (DBE,
Spirometer exercises) with a respiratory therapist to help breathing.
CONT..
• Ineffective breathing pattern related to imbalance between supply and
demand of oxygen evidence by shortness of breath.
• Ineffective airway clearance related to broncho constriction.
• Self care deficit related to fatigue secondary to increased effort for
breathing evidence by poor personal hygiene.
• Activity intolerance due to fatigue and ineffective breathing patterns
evidenced by weakness, fatigue.
NURSING DIAGNOSES
• Assess the condition of patient.
• Assess the vital signs
• Provide comfortable position.
• Change the position periodically.
• Maintain personal hygiene.
• Use pulse oximetry & suction.
• Deep breathing exercise learn to patient.
NURSING INTERVENTIONS
• Refer to physiotherapist (if need).
• Provide oxygen according to physician order.
• Provide psychological support to patient.
• Provide knowledge about chronic bronchitis.
• Administer medication according to physician order bronchodilators,
antibiotics, mucolytics.
CONT..
• Asthma
• Bronchiectasis
• Tuberculosis
COMPLICATIONS
• Avoiding tobacco smoke and exposure to second hand smoke
• Quitting smoking
• Avoiding people who are sick with colds or the flu
• Getting a yearly flu vaccine
• Getting a pneumonia vaccine
• Washing hands regularly
• Avoiding cold, damp locations or areas with a lot of air pollution
• Wearing a mask around people who are coughing and sneezing
HEALTH EDUCATION
Bronchiectasis is a condition anatomically defined by chronic, irreversible
dilation and distortion of the bronchi caused by inflammatory destruction
of the muscular and elastic components of the bronchial walls.
OR
Bronchiectasis is defined as permanent, abnormal dilatation of one or
more large bronchi.
DEFINITION
• Cylindrical (fusiform)
• Saccular
• Varicose
CLASSIFICATION
1. Cylindrical/tubular bronchiectasis
The luminal dilatation is uniform and
the wall thickening is smooth and there
is failure of normal tapering of the
bronchi.
CONT..
2. Saccular or cystic bronchiectasis
Most severe form of bronchiectasis. The bronchi are severely dilated and
the bronchi end blindly in a dilated thick walled cyst.
CONT..
3. Varicose bronchiectasis
The bronchi resemble like varicose veins.
The luminal dilation is characterized by
alternating areas of luminal dilation and
constriction, creating a beaded appearance,
and the wall thickening is irregular.
CONT..
• Bronchiectasis has both congenital and acquired causes.
1. CONGENITAL CAUSES
• Kartagener syndrome/ Immotile Ciliary Syndrome: autosomal
recessive disorder, defect in the action of cilia.
• Primary immunodeficiencies.
• Williams-Campbell syndrome: Also known as Broncho-malacia is a
disease of the airways where cartilage in the bronchi is defective.
ETIOLOGY
• Marfan 's syndrome: Disorder of connective tissue, resulting in
abnormally long and thin digits.
• Patients with alpha I-antitrypsin deficiency
CONT..
2. ACQUIRED CAUSES
• Infections caused by the staphylococcus, klebsiella, or the causative
agent of whooping cough, Tuberculosis, allergic bronchopulmonary
aspergillosis
• Chronic bronchitis
• Bronchial tumor
• Inhaled foreign bodies
• Alcoholism, heroin (drug use),
• Inflammatory bowel disease, especially ulcerative colitis.
• A Hiatal hernia can cause Bronchiectasis when the stomach acid
aspirated into the lungs.
CONT..
• The production of large quantities of purulent and often foul-
smelling sputum. The volume of sputum can be used for estimating
the severity of the disease.
• Mild < 10 mL
• Moderate 10-150 ml.
• Severe > 150 mL
CLINICAL MANIFESTATIONS
• Chronic cough
• Hemoptysis:
– Frequent.
– More commonly in dry variety.
– Usually mild
• Recurrent pneumonia: same segment
• Systemic manifestations: fever, weight loss
CONT..
• History and physical examination
• Chest x- rays
• Sputum cultures
• Blood test
• Pulmonary function test
• CT scan thorax
• ABG analysis
• Bronchoscopy
• Immunoglobulin
• Cilia function and structure — Kartagener syndrome.
INVESTIGATIONS
Goals:
l. Eliminate cause
2. Improve tracheobronchial clearance
3. Control infection
4. Reverse airflow obstruction
TREATMENT
• Immunoglobulin
• Antituberculosis drugs.
• Corticosteroids.
• Remove aspirated material
• Oxygen therapy
• Chest physio- therapy
• Postural drainage.
CONT..
• Mucolytics.
• Bronchodilators.
• Antibiotics: The choice of antibiotics should be accurately by the
results of sputum culture and drug sensitivity test.
CONT..
• Surgery
– Bronchial artery embolization
– Pneumonectomy
– Lobectomy
– Wedge resection
– Segmentectomy
– Sleeve lobectomy
– Lung transplantation
CONT..
Bronchial artery embolization:
A catheter is used to deliver small particles that block the blood supply
to the particular part of body. (Hemoptysis)
CONT..
Pneumonectomy: A surgical procedure in
which an entire lung is removed. A
pneumonectomy is an open chest technique
(thoracotomy).
Lobectomy: removes one lobe of the lung.
Removal of two lobes is called bilobectomy.
CONT..
Sleeve resection: Removing a lobe of
the lung along with part of the
bronchus.
Segment Resection (Segmentectomy):
Removal of the larger portion of the
lung but not the whole lobe .
CONT..
• Natural therapy
• Yoga
• Healthy lifestyle
• Emotional support
• Drug free salt therapy
PREVENTIVE MODALITIES
• The inhalation of natural pure sodium chloride (NaCl) in a
controlled environment (air temperature 18° to 24°C and relative
humidity 40% to 60%) is called halotherapy.
• Salt therapy is a gentle, non-invasive and drug free treatment
assisting the body to cleanse itself of toxins and naturally improve
general health and wellbeing.
• Salt has natural healing properties that help sufferers of respiratory
issues, skin problems and is also great for overall health.
Drug free salt therapy (halotherapy)
• A device called a halogenerator grinds salt into microscopic
particles and releases them into the air of the room. Once inhaled,
these salt particles are claimed to absorb irritants, including
allergens and toxins, from the respiratory system.
• The therapy involves sitting and relaxing in a specially designed
salt room and breathing in the microscopic salt particles.
• Sessions usually last for about 30 to 45 minutes.
Cont..
• Impaired gas exchange related to ventilation—perfusion inequality as
evidenced by decreased level of Sp02
Goal: Improvement in gas exchange
• Ineffective clearance related to increased production, ineffective
bronchopulmonary infection, and complications
Goal: Achievement of airway clearance airway mucus cough, other
NURSING DIAGNOSES
• Respiratory failure
• Atelectasis
COMPLICATIONS

More Related Content

Similar to LRTIs_025720.pptx

cough approach by aMit!!! GMCH
cough approach by aMit!!! GMCHcough approach by aMit!!! GMCH
cough approach by aMit!!! GMCH
aMit!!!
 
Chronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diaseseChronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diasese
Mahesh Chand
 
asthma BSc nursing 2nd year.pptx
asthma BSc nursing 2nd year.pptxasthma BSc nursing 2nd year.pptx
asthma BSc nursing 2nd year.pptx
kashischaudhary
 
Adult1 05c ptb
Adult1 05c ptbAdult1 05c ptb
Adult1 05c ptb
WesamMagh
 
Acute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptxAcute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptx
elizadoyce1
 
Pneumonia & bronchiolitis
Pneumonia & bronchiolitisPneumonia & bronchiolitis
Pneumonia & bronchiolitis
dhaval joshi
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
BPT4thyearJamiaMilli
 
pneumonia.pptx
pneumonia.pptxpneumonia.pptx
pneumonia.pptx
Koyel Thander
 
Pediatric pneumonia.pptx
Pediatric pneumonia.pptxPediatric pneumonia.pptx
Pediatric pneumonia.pptx
DrHananTork
 
pulmonary rehabilitation
pulmonary rehabilitationpulmonary rehabilitation
pulmonary rehabilitation
mrinal joshi
 
Respiratory disease
Respiratory diseaseRespiratory disease
Respiratory disease
Zuhair Mustafa
 
Asthma_NZD.pptx
Asthma_NZD.pptxAsthma_NZD.pptx
Asthma_NZD.pptx
Fridahchungu
 
Bronchectasis
BronchectasisBronchectasis
Bronchectasis
THANUJA MATHEW
 
Bronchitis
BronchitisBronchitis
Bronchitis
Hari Nagar
 
clinical features of tb.ppt
clinical features of tb.pptclinical features of tb.ppt
clinical features of tb.ppt
ShakibSheikh5
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
rajendra gopal
 
Acute laryngotracheobronchitis bondi
Acute laryngotracheobronchitis bondiAcute laryngotracheobronchitis bondi
Acute laryngotracheobronchitis bondi
Sasha Bondi
 
Cvr revision copy
Cvr revision copyCvr revision copy
Cvr revision copy
sleeming
 

Similar to LRTIs_025720.pptx (20)

cough approach by aMit!!! GMCH
cough approach by aMit!!! GMCHcough approach by aMit!!! GMCH
cough approach by aMit!!! GMCH
 
Chronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diaseseChronic Obstructive pulmonary diasese
Chronic Obstructive pulmonary diasese
 
asthma BSc nursing 2nd year.pptx
asthma BSc nursing 2nd year.pptxasthma BSc nursing 2nd year.pptx
asthma BSc nursing 2nd year.pptx
 
Adult1 05c ptb
Adult1 05c ptbAdult1 05c ptb
Adult1 05c ptb
 
Acute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptxAcute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptx
 
Pneumonia & bronchiolitis
Pneumonia & bronchiolitisPneumonia & bronchiolitis
Pneumonia & bronchiolitis
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
pneumonia.pptx
pneumonia.pptxpneumonia.pptx
pneumonia.pptx
 
Pediatric pneumonia.pptx
Pediatric pneumonia.pptxPediatric pneumonia.pptx
Pediatric pneumonia.pptx
 
pulmonary rehabilitation
pulmonary rehabilitationpulmonary rehabilitation
pulmonary rehabilitation
 
Pneu
PneuPneu
Pneu
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Respiratory disease
Respiratory diseaseRespiratory disease
Respiratory disease
 
Asthma_NZD.pptx
Asthma_NZD.pptxAsthma_NZD.pptx
Asthma_NZD.pptx
 
Bronchectasis
BronchectasisBronchectasis
Bronchectasis
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
clinical features of tb.ppt
clinical features of tb.pptclinical features of tb.ppt
clinical features of tb.ppt
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Acute laryngotracheobronchitis bondi
Acute laryngotracheobronchitis bondiAcute laryngotracheobronchitis bondi
Acute laryngotracheobronchitis bondi
 
Cvr revision copy
Cvr revision copyCvr revision copy
Cvr revision copy
 

More from ShubhrimaKhan

HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
ShubhrimaKhan
 
Plural effusion_092054.pptx
Plural effusion_092054.pptxPlural effusion_092054.pptx
Plural effusion_092054.pptx
ShubhrimaKhan
 
PNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptxPNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptx
ShubhrimaKhan
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
ShubhrimaKhan
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
ShubhrimaKhan
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
ShubhrimaKhan
 
Lung abscess_102210.pptx
Lung abscess_102210.pptxLung abscess_102210.pptx
Lung abscess_102210.pptx
ShubhrimaKhan
 
Spinal cord injury_040036.pptx
Spinal cord injury_040036.pptxSpinal cord injury_040036.pptx
Spinal cord injury_040036.pptx
ShubhrimaKhan
 
COPD
COPDCOPD
GB syndrome_015823.pptx
GB syndrome_015823.pptxGB syndrome_015823.pptx
GB syndrome_015823.pptx
ShubhrimaKhan
 
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptxPlural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
ShubhrimaKhan
 
multiple sclerosis_063233.pptx
multiple sclerosis_063233.pptxmultiple sclerosis_063233.pptx
multiple sclerosis_063233.pptx
ShubhrimaKhan
 
Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
ShubhrimaKhan
 
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptxUPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
ShubhrimaKhan
 
EXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptxEXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptx
ShubhrimaKhan
 
Webiner.pptx
Webiner.pptxWebiner.pptx
Webiner.pptx
ShubhrimaKhan
 
Dissertation
DissertationDissertation
Dissertation
ShubhrimaKhan
 
Respiratory_Tract_Infection
Respiratory_Tract_Infection Respiratory_Tract_Infection
Respiratory_Tract_Infection
ShubhrimaKhan
 
pain_103744.pptx
pain_103744.pptxpain_103744.pptx
pain_103744.pptx
ShubhrimaKhan
 
skin infections_020627.pptx
skin infections_020627.pptxskin infections_020627.pptx
skin infections_020627.pptx
ShubhrimaKhan
 

More from ShubhrimaKhan (20)

HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
 
Plural effusion_092054.pptx
Plural effusion_092054.pptxPlural effusion_092054.pptx
Plural effusion_092054.pptx
 
PNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptxPNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
Lung abscess_102210.pptx
Lung abscess_102210.pptxLung abscess_102210.pptx
Lung abscess_102210.pptx
 
Spinal cord injury_040036.pptx
Spinal cord injury_040036.pptxSpinal cord injury_040036.pptx
Spinal cord injury_040036.pptx
 
COPD
COPDCOPD
COPD
 
GB syndrome_015823.pptx
GB syndrome_015823.pptxGB syndrome_015823.pptx
GB syndrome_015823.pptx
 
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptxPlural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
 
multiple sclerosis_063233.pptx
multiple sclerosis_063233.pptxmultiple sclerosis_063233.pptx
multiple sclerosis_063233.pptx
 
Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
 
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptxUPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
 
EXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptxEXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptx
 
Webiner.pptx
Webiner.pptxWebiner.pptx
Webiner.pptx
 
Dissertation
DissertationDissertation
Dissertation
 
Respiratory_Tract_Infection
Respiratory_Tract_Infection Respiratory_Tract_Infection
Respiratory_Tract_Infection
 
pain_103744.pptx
pain_103744.pptxpain_103744.pptx
pain_103744.pptx
 
skin infections_020627.pptx
skin infections_020627.pptxskin infections_020627.pptx
skin infections_020627.pptx
 

Recently uploaded

Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 

Recently uploaded (20)

Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 

LRTIs_025720.pptx

  • 2. • Infections of the lower respiratory tract includes – – Acute bronchitis – Pneumonia – Pneumothorax – Atelectasis – Tuberculosis – Pertussis – Lung abscess – Pulmonary embolism – Plural effusion LRTIs
  • 3. Presented by – SHUBHRIMA KHAN RINMS, DURGAPUR
  • 4.
  • 5.
  • 6. 1. According to the causative organisms (a)Bacterial :- • Pneumococcal pneumonia caused by Streptococcus pneumoniae* • Staphylococcal pneumonia caused by Staphylococcus aureus • Influenzal pneumonia caused by Haemophiles influenza • Gram-negative bacterial pneumonia caused by Klebsiella pneumonia CLASSIFICATION
  • 7. b) Viral:- Rhinovirus, coronaviruses, influenza virus, respiratory syncytial virus (RSV), adenovirus and parainfluenza. People following organ transplantation or immunocompromised present high rates of cytomegalovirus pneumonia. c) Fungal:- Fungal pneumonia caused by histoplasmosis, aspergillosis, candidiasis, blastomycosis d) Parasitic:- Parasitic pneumonia (caused by protozoa, nematodes, Platyhelminthes) CONT..
  • 8. 2. According to the environment a) Community-acquired pneumonia. b) Hospital acquired pneumonia. c) Ventilator acquired Pneumonia. (VAP) d) Pneumonia in the immuno-compromised host (opportunistic pneumonia). e) Aspiration pneumonia CONT..
  • 9. 3. According to the areas of the lung involved/affected a) Lobar pneumonia b) Multilobed pneumonia c) Bronchial pneumonia d) Interstitial pneumonia e) Alveolar (acinar) pneumonia f) Segmental pneumonia CONT..
  • 10. • There are many causes of pneumonia including bacteria, viruses, mycoplasmas, fungal agents and protozoa. • It may also result from inhalation of toxic or caustic chemicals, smoke, dusts or gases or aspiration of food, fluids, or vomitus. • Pneumonia may complicate to chronic illnesses. ETIOLOY
  • 11. • Age 60 or older • Smoking • Air pollution, Inhalation of noxious substances. • Altered consciousness : Alcoholism, head injury, anesthetic drug overdose • Tracheal intubation • Upper Respiratory Tract Infection • Chronic Disease : Chronic lung disease, Diabetes mellitus, heart disease, cancer RISK FACTORS
  • 12. • Immunosuppression • Malnutrition • Prolonged bed rest and immobility • Aspiration of fluid, liquid, foreign or gastric content. • Prolonged hospital stay. • Residence in institutional areas where transmission is prone. CONT..
  • 13.
  • 14.
  • 15. • Fever • Chills and sweating • Productive cough • Shortness of breath • Chest pain • Hypoxemia • Fatigue • Dyspnea, Tachypnea CLINICAL MANIFESTATION
  • 16. • Hemoptysis • Headache • Crackling sounds over affected area • Dullness on percussion • Decrease in breath sounds • Unequal chest expansion CONT..
  • 17. • Physical examination. • Chest X-ray. • Gram stain and culture and sensitivity tests of sputum. • Blood culture. • Immunologic test to detect microbial antigens. • CT Scan thorax. • Fiberoptic bronchoscopy or transcutaneous needle aspiration [biopsy]. • ABG. DIAGNOSTIC EVALUATION
  • 18. • Appropriate antibiotic therapy – Macrolide antibiotics: inhibitors of bacterial protein synthesis such as azithromycin, clarithromycin – Fluroquinolones: inhibitors of DNA synthesis such as moxifloxacin, levofloxacin –  lactams: inhibitors of bacterial cell wall synthesis (Penicillin, amoxicillin, clavulanate (Augmentin), ceftriaxone, cefuroxime, tazobactam, meropenem) • Antipyretic • Analgesic • Bronchodilators medications: albuterol sulphate, metaproterenol or methylxanthines. MANAGEMENT
  • 19. • Oxygen therapy • Nutritional support • Fluid and electrolyte management • Deep breathing exercises and spirometry • Chest physiotherapy • Nasotracheal suctioning CONT..
  • 20. NURSING DIAGNOSIS 1. Impaired gas exchange related to presence of retained secretions at the capillary alveolar membrane evidenced by cyanosis, dyspnea, confusion, hypoxia INTERVENTION • Assess the respiratory status, skin colour, mental status, heart rhythm and body temperature. • Auscultate lung fields. • Elevate head of bed. • Suctioning is to be done as indicated. • Encourage fluids to at least 2500 mL per day, unless contraindicated. NURSING MANAGEMENT
  • 21. • Assist with and monitor effects of nebulizer treatments and other. • Perform chest physiotherapy, incentive spirometer. • Administer medications, as indicated, for example, mucolytics, expectorants, bronchodilators, and analgesics. • Provide supplemental fluids such as IV infusion, humidified oxygen, and room humidification. • Monitor serial chest x-rays, ABGs, and pulse oximetry readings. CONT..
  • 22. NURSING DIAGNOSIS 2. Ineffective breathing pattern related to inflammation and pain evidenced by Changes in respiratory rate, diminished/adventitious breath sounds, Ineffective cough. INTERVENTION • Assess rate, depth of respirations and chest movement. • Elevate head and encourage frequent position changes, deep breathing, and effective coughing. • Maintain bedrest • Monitor ABGs and pulse oximetry. • Administer oxygen therapy by appropriate CONT..
  • 23. NURSING DIAGNOSIS 3. Activity Intolerance relate to imbalance between oxygen supply and demand, General weakness evidenced by report of weakness, fatigue, exertional dyspnea or tachypnea, Abnormal heart rate response to activity. INTERVENTION • Evaluate client's response to activity. • Note reports of dyspnea, increased weakness and fatigue, and changes in vital signs during and after activities • Provide a quiet environment and limit visitors during acute phase • Encourage use of stress management and diversional activities. • Explain importance of balancing activities with rest. • Assist with self-care activities as necessary. CONT..
  • 24. NURSING DIAGNOSIS 4. Knowledge deficit regarding condition, treatment, self care, discharge needs, related to lack of exposure , information misinterpretation as evidenced by reports the problem, inaccurate follow-through of instructions. INTERVENTION • Assess the level of understanding of the patient and knowledge. • Explain about the disease condition, its signs and symptoms and treatment modalities. • Explain and demonstrate about the importance of effective coughing and deep breathing exercises. CONT..
  • 25. • Emphasis necessity of continuing antimicrobial therapy. • Explain about balanced rest and activity, avoiding smoking, well-rounded diet, and avoidance of crowds during cold and flu season and of persons with upper respiratory infections. • Stress importance of continuing medical follow-up and obtaining vaccinations and immunizations as appropriate for both children and adults. CONT..
  • 26. NURSING DIAGNOSIS 5. Deficient fluid volume R/t fever, diaphoresis & mouth breathing. 6. Imbalanced nutrition: less than body requirements R/t dyspnea, poor oral intake. 7. Pain R/t frequent coughing 8. Impaired oral mucous membrane R/t mouth breathing & frequent cough. CONT..
  • 27.
  • 28. • Advise patient to complete entire course of antibiotics. • Once clinically stable, encourage gradual increase in activities to bring energy level back to pre-illness stage. • Encourage breathing exercises. • Explain that a chest X-ray is usually taken 4 to 6 weeks after recovery. • Advise smoking cessation and avoid excessive alcohol intake. • Advise patient to keep up natural resistance with good nutrition and adequate rest. • Advice patient to practice frequent handwashing, especially after contact with others. PATIENT EDUCATION
  • 29.
  • 30. Bronchitis is inflammation or swelling of the bronchial tubes (bronchi). More specifically, bronchitis is when the lining of the bronchial tubes becomes inflamed or infected. DEFINITION
  • 31. Acute bronchitis Acute bronchitis is a shorter illness that commonly follows a cold or viral infection, such as the flu. Acute bronchitis usually lasts a few days or weeks Chronic bronchitis Chronic bronchitis is characterized by a persistent, mucus-producing cough on most days of the month, three months of a year for two successive years in absence of a secondary cause of the cough. TYPES
  • 32. • Viruses, bacteria, and other particles that irritate the bronchial tubes. • Smokers: People who are exposed to a lot of secondhand smoke • People with weakened immune systems • The elderly and infants • People with gastroesophageal reflux disease (GERD) • People who are exposed to air pollution ETIOLOGY
  • 33. • Coughing • Production of clear, white, yellow, grey, or green mucus (sputum) • Shortness of breath • Wheezing • Fatigue • Fever and chills • Chest pain or discomfort • Blocked or runny nose CLINICAL MANIFESTATIONS
  • 34. History collection Physical examination Chest x- rays Sputum cultures Pulmonary function test Bronchoscopy INVESTIGATIONS
  • 35. • Antibiotics - these are effective for bacterial infections, but not for viral infections. They may also prevent secondary infections. • Cough medicine - one must be careful not to completely suppress the cough, for it is an important way to bring up mucus and remove irritants from the lungs. • Bronchodilators - these open the bronchial tubes and clear out mucus MEDICAL MANAGEMENT
  • 36. • Mucolytics - these thin or loosen mucus in the airways, making it easier to cough up sputum. • Anti-inflammatory medicines and glucocorticoid steroids - these are for more persistent symptoms. • Pulmonary rehabilitation program - this includes work (DBE, Spirometer exercises) with a respiratory therapist to help breathing. CONT..
  • 37. • Ineffective breathing pattern related to imbalance between supply and demand of oxygen evidence by shortness of breath. • Ineffective airway clearance related to broncho constriction. • Self care deficit related to fatigue secondary to increased effort for breathing evidence by poor personal hygiene. • Activity intolerance due to fatigue and ineffective breathing patterns evidenced by weakness, fatigue. NURSING DIAGNOSES
  • 38. • Assess the condition of patient. • Assess the vital signs • Provide comfortable position. • Change the position periodically. • Maintain personal hygiene. • Use pulse oximetry & suction. • Deep breathing exercise learn to patient. NURSING INTERVENTIONS
  • 39. • Refer to physiotherapist (if need). • Provide oxygen according to physician order. • Provide psychological support to patient. • Provide knowledge about chronic bronchitis. • Administer medication according to physician order bronchodilators, antibiotics, mucolytics. CONT..
  • 40. • Asthma • Bronchiectasis • Tuberculosis COMPLICATIONS
  • 41. • Avoiding tobacco smoke and exposure to second hand smoke • Quitting smoking • Avoiding people who are sick with colds or the flu • Getting a yearly flu vaccine • Getting a pneumonia vaccine • Washing hands regularly • Avoiding cold, damp locations or areas with a lot of air pollution • Wearing a mask around people who are coughing and sneezing HEALTH EDUCATION
  • 42.
  • 43. Bronchiectasis is a condition anatomically defined by chronic, irreversible dilation and distortion of the bronchi caused by inflammatory destruction of the muscular and elastic components of the bronchial walls. OR Bronchiectasis is defined as permanent, abnormal dilatation of one or more large bronchi. DEFINITION
  • 44.
  • 45. • Cylindrical (fusiform) • Saccular • Varicose CLASSIFICATION
  • 46. 1. Cylindrical/tubular bronchiectasis The luminal dilatation is uniform and the wall thickening is smooth and there is failure of normal tapering of the bronchi. CONT..
  • 47. 2. Saccular or cystic bronchiectasis Most severe form of bronchiectasis. The bronchi are severely dilated and the bronchi end blindly in a dilated thick walled cyst. CONT..
  • 48. 3. Varicose bronchiectasis The bronchi resemble like varicose veins. The luminal dilation is characterized by alternating areas of luminal dilation and constriction, creating a beaded appearance, and the wall thickening is irregular. CONT..
  • 49. • Bronchiectasis has both congenital and acquired causes. 1. CONGENITAL CAUSES • Kartagener syndrome/ Immotile Ciliary Syndrome: autosomal recessive disorder, defect in the action of cilia. • Primary immunodeficiencies. • Williams-Campbell syndrome: Also known as Broncho-malacia is a disease of the airways where cartilage in the bronchi is defective. ETIOLOGY
  • 50. • Marfan 's syndrome: Disorder of connective tissue, resulting in abnormally long and thin digits. • Patients with alpha I-antitrypsin deficiency CONT..
  • 51. 2. ACQUIRED CAUSES • Infections caused by the staphylococcus, klebsiella, or the causative agent of whooping cough, Tuberculosis, allergic bronchopulmonary aspergillosis • Chronic bronchitis • Bronchial tumor • Inhaled foreign bodies • Alcoholism, heroin (drug use), • Inflammatory bowel disease, especially ulcerative colitis. • A Hiatal hernia can cause Bronchiectasis when the stomach acid aspirated into the lungs. CONT..
  • 52.
  • 53. • The production of large quantities of purulent and often foul- smelling sputum. The volume of sputum can be used for estimating the severity of the disease. • Mild < 10 mL • Moderate 10-150 ml. • Severe > 150 mL CLINICAL MANIFESTATIONS
  • 54. • Chronic cough • Hemoptysis: – Frequent. – More commonly in dry variety. – Usually mild • Recurrent pneumonia: same segment • Systemic manifestations: fever, weight loss CONT..
  • 55. • History and physical examination • Chest x- rays • Sputum cultures • Blood test • Pulmonary function test • CT scan thorax • ABG analysis • Bronchoscopy • Immunoglobulin • Cilia function and structure — Kartagener syndrome. INVESTIGATIONS
  • 56. Goals: l. Eliminate cause 2. Improve tracheobronchial clearance 3. Control infection 4. Reverse airflow obstruction TREATMENT
  • 57. • Immunoglobulin • Antituberculosis drugs. • Corticosteroids. • Remove aspirated material • Oxygen therapy • Chest physio- therapy • Postural drainage. CONT..
  • 58. • Mucolytics. • Bronchodilators. • Antibiotics: The choice of antibiotics should be accurately by the results of sputum culture and drug sensitivity test. CONT..
  • 59. • Surgery – Bronchial artery embolization – Pneumonectomy – Lobectomy – Wedge resection – Segmentectomy – Sleeve lobectomy – Lung transplantation CONT..
  • 60. Bronchial artery embolization: A catheter is used to deliver small particles that block the blood supply to the particular part of body. (Hemoptysis) CONT..
  • 61. Pneumonectomy: A surgical procedure in which an entire lung is removed. A pneumonectomy is an open chest technique (thoracotomy). Lobectomy: removes one lobe of the lung. Removal of two lobes is called bilobectomy. CONT..
  • 62. Sleeve resection: Removing a lobe of the lung along with part of the bronchus. Segment Resection (Segmentectomy): Removal of the larger portion of the lung but not the whole lobe . CONT..
  • 63. • Natural therapy • Yoga • Healthy lifestyle • Emotional support • Drug free salt therapy PREVENTIVE MODALITIES
  • 64. • The inhalation of natural pure sodium chloride (NaCl) in a controlled environment (air temperature 18° to 24°C and relative humidity 40% to 60%) is called halotherapy. • Salt therapy is a gentle, non-invasive and drug free treatment assisting the body to cleanse itself of toxins and naturally improve general health and wellbeing. • Salt has natural healing properties that help sufferers of respiratory issues, skin problems and is also great for overall health. Drug free salt therapy (halotherapy)
  • 65. • A device called a halogenerator grinds salt into microscopic particles and releases them into the air of the room. Once inhaled, these salt particles are claimed to absorb irritants, including allergens and toxins, from the respiratory system. • The therapy involves sitting and relaxing in a specially designed salt room and breathing in the microscopic salt particles. • Sessions usually last for about 30 to 45 minutes. Cont..
  • 66. • Impaired gas exchange related to ventilation—perfusion inequality as evidenced by decreased level of Sp02 Goal: Improvement in gas exchange • Ineffective clearance related to increased production, ineffective bronchopulmonary infection, and complications Goal: Achievement of airway clearance airway mucus cough, other NURSING DIAGNOSES
  • 67. • Respiratory failure • Atelectasis COMPLICATIONS